This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Inven2 as. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Karl-Johan Malmberg: Innovator in Immunotherapy
Introduction
Karl-Johan Malmberg is a prominent inventor based in Oslo, Norway. He has made significant contributions to the field of immunotherapy, particularly through his innovative approaches to natural killer (NK) cell expansion. His work is vital in advancing therapeutic methods for various diseases.
Latest Patents
Malmberg holds a patent titled "Selective and controlled expansion of educated NK cells." This invention relates to immunotherapy and discloses methods for obtaining cytolytic differentiated NKG2ANKG2C cells with specific KIR specificity. The patent also includes compositions comprising these cells and their therapeutic uses. Notably, the NK cell expansion methods described have potential non-therapeutic applications as well. He has 1 patent to his name.
Career Highlights
Karl-Johan Malmberg is associated with Inven2 AS, where he continues to develop his groundbreaking ideas in immunotherapy. His work has garnered attention for its potential to revolutionize treatment options for patients.
Collaborations
Malmberg collaborates with Vivien Beziat, contributing to the advancement of their shared research interests in immunotherapy.
Conclusion
Karl-Johan Malmberg's innovative work in the field of immunotherapy highlights his commitment to improving therapeutic strategies through scientific research. His contributions are paving the way for future advancements in medical treatments.